| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |